Design, synthesis and activity of a potent, selective series of N -aryl pyridinone inhibitors of p38 kinase-Reference-Cited by-同舟云学术

Design, synthesis and activity of a potent, selective series of N -aryl pyridinone inhibitors of p38 kinase

Published:2011-07 Issue:13 Volume:21 Page:4059-4065
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Selness Shaun R.,Boehm Terri L.,Walker John K.,Devadas Balekudru,Durley Richard C.,Kurumbail Ravi,Shieh Huey,Xing Li,Hepperle Michael,Rucker Paul V.,Jerome Kevin D.,Benson Alan G.,Marrufo Laura D.,Madsen Heather M.,Hitchcock Jeff,Owen Tom J.,Christie Lance,Promo Michele A.,Hickory Brian S.,Alvira Edgardo,Naing Win,Blevis-Bal Radhika,Devraj Rajesh V.,Messing Dean,Schindler John F.,Hirsch Jeffrey,Saabye Matthew,Bonar Sheri,Webb Elizabeth,Anderson Gary,Monahan Joseph B.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference12 articles.

1. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis

2. Efficacy and safety of retreatment with anti–tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease

3. Systemic anti-tumor necrosis factor α therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor α synthesis

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioactive atropisomers: Unraveling design strategies and synthetic routes for drug discovery;Medicinal Research Reviews;2024-03-21

2. Recent Advances of Pyridinone in Medicinal Chemistry;Frontiers in Chemistry;2022-03-23

3. Organocatalyzed Enantioselective Michael Addition of 2‐Hydroxypyridines and α,β‐Unsaturated 1,4‐Dicarbonyl Compounds;Advanced Synthesis & Catalysis;2019-09-06

4. Medicinal Chemistry Case History: Structure-Based Drug Design of Oral and Inhaled p38 MAP Kinase Inhibitors as Clinical Candidates;Comprehensive Medicinal Chemistry III;2017

5. Structure-based de novo design and synthesis of aminothiazole-based p38 MAP kinase inhibitors;Bioorganic & Medicinal Chemistry Letters;2015-09